Table 4. Potential associated factors of GWW and GWE in SLE patients.
Variables | Univariable analysis | Multivariable analysis | |||
---|---|---|---|---|---|
β-coefficient | P value | β-coefficient | P value | ||
GWW | |||||
ESR | 0.539 | <0.001 | 0.189 | <0.001 | |
CRP | 0.695 | <0.001 | 0.230 | <0.001 | |
Anti-phospholipid antibodies | 0.817 | <0.001 | 0.444 | <0.001 | |
Anti-nuclear antibody | 0.095 | 0.279 | |||
Anti-Smith antibodies | −0.004 | 0.966 | |||
HP | 0.087 | 0.322 | |||
SLEDAI score | 0.719 | <0.001 | 0.180 | <0.001 | |
Duration | 0.159 | 0.069 | 0.048 | 0.140 | |
LAVI | 0.313 | <0.001 | 0.039 | 0.305 | |
IVSd | 0.172 | 0.048 | 0.035 | 0.290 | |
PWTd | 0.093 | 0.291 | |||
E/A | 0.409 | <0.001 | 0.074 | 0.049 | |
E/e’ | 0.444 | <0.001 | −0.003 | 0.932 | |
PSD | 0.675 | <0.001 | 0.111 | 0.009 | |
GWE | |||||
ESR | −0.498 | <0.001 | −0.184 | <0.001 | |
CRP | −0.610 | <0.001 | −0.130 | 0.013 | |
Anti-phospholipid antibodies | −0.796 | <0.001 | −0.468 | <0.001 | |
Anti-nuclear antibody | −0.091 | 0.298 | |||
Anti-Smith antibodies | −0.035 | 0.688 | |||
HP | −0.067 | 0.444 | |||
SLEDAI score | −0.689 | <0.001 | −0.191 | 0.001 | |
Duration | −0.161 | 0.066 | −0.059 | 0.167 | |
LAVI | −0.293 | 0.001 | −0.053 | 0.276 | |
IVSd | −0.153 | 0.079 | −0.021 | 0.635 | |
PWTd | −0.111 | 0.205 | |||
E/A | −0.386 | <0.001 | −0.081 | 0.095 | |
E/e’ | −0.373 | <0.001 | 0.081 | 0.110 | |
PSD | −0.665 | <0.001 | −0.149 | 0.007 |
GWW, global wasted work; GWE, global work efficiency; SLE, systemic lupus erythematosus; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; HP, hypertension; SLEDAI, SLE Disease Activity Index; LAVI, left atrial volume index; IVSd, interventricular septum thickness in diastole; E/A, peak early diastolic velocity/peak late diastolic velocity; E/e’, peak early diastolic velocity (by pulsed-wave Doppler)/early diastolic peak velocity (by tissue Doppler); PSD, peak strain dispersion; PWTd, posterior wall thickness in diastole.